This reprogramming is mediated by Th2-skewing cytokines (e.g., IL-4, TGF-β1) and tumor-derived growth factors (e.g., CSF1, GM-CSF), fostering a microenvironment that supports tumor growth and metastasis (18). The gene discussed is CSF2; the disease is neoplasm.